The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows.
They were chosen from an extremely strong field of 47 applicants from across the scientific and clinical community because they demonstrated that their research was high impact and of high quality .
They were also able to demonstrate leadership, independence and collaboration with other research groups.
The seven fellows are:
- Katie Ewer is senior immunologist for Oxford’s Ebola and pre-erythrocytic malaria vaccine trials. She oversees the immunology on Phase I and II trials of vectored vaccines, both in the UK and in field trials in Africa. (Vaccines for Emerging and Endemic Diseases)
- David Eyre is an infectious diseases clinician. His research interests are focused on quantitative epidemiological studies of infectious diseases and the use of metagenomic pathogen sequencing as a tool for diagnosing infection and antimicrobial resistance. (Antimicrobial Resistance and Modernising Microbiology)
- Xavier Griffin is a trauma surgeon whose research interest is in the clinical and cost effectiveness of musculoskeletal trauma interventions. (Musculoskeletal)
- Tim Hinks is a clinician-scientist investigating the immunopathogenesis of airway diseases and pulmonary infections with a specific focus on the role of T cells in asthma and during chronic airways infection. (Respiratory)
- Simon Kyle is a research scientist whose research focuses on the aetiology of chronic sleep disruption, the interplay between sleep and cognitive health, and the development of mechanistically-grounded treatments for sleep disorders. (Neurological Conditions)
- Philippa Matthews is a research fellow in clinical infection working on a study of chronic hepatitis B virus (HBV) infection, with a particular focus on populations in southern Africa. (Antimicrobial Resistance & Modernising Microbiology)
- James Sheppard is a population health scientist interested in better understanding the benefits and harms of treatments, with a particular focus on cardiovascular disease prevention. (Multi-morbidity and Long-term Conditions)
The aim of the fellowships is to support individuals to advance an independent research area which will enhance BRC research in Oxford and strengthen future BRC funding applications.
The fellows will receive an award of £10,000 per year for a period of two years that can be used flexibly to facilitate their translational research programme and career development.
They will also have the chance to take part in a series of masterclasses and network with principal BRC fellows.